{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:19:06Z","timestamp":1791472746591,"version":"4.3.4"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T00:00:00Z","timestamp":1215561600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0002636","type":"journal-article","created":{"date-parts":[[2008,7,9]],"date-time":"2008-07-09T03:59:18Z","timestamp":1215575958000},"page":"e2636","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":350,"title":["Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51"],"prefix":"10.1371","volume":"3","clinical-trial-number":[{"clinical-trial-number":"nct00295581","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Yimin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth D.","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Fontes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa M.","family":"Malkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhartha","family":"Mahanty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Fay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Narum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Rausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron P.","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Aebig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Orcutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Muratova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daming","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutoyo","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Saul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P.","family":"Durbin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2008,7,9]]},"reference":[{"key":"ref1","article-title":"World Malaria Report.","year":"2005"},{"key":"ref2","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000363.pub2","article-title":"Insecticide-treated bed nets and curtains for preventing malaria.","volume":"CD000363","author":"C Lengeler","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1475-2875-6-107","article-title":"Transmission-blocking activity induced by malaria vaccine candidates Pfs25\/Pvs25 is a direct and predictable function of antibody titer.","volume":"6","author":"K Miura","year":"2007","journal-title":"Malar J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000058850","article-title":"Transmission-blocking vaccines.","volume":"80","author":"DC Kaslow","year":"2002","journal-title":"Chem Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.vaccine.2004.12.019","article-title":"Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.","volume":"23","author":"EM Malkin","year":"2005","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.pt.2005.07.005","article-title":"Revisiting Freund&apos;s incomplete adjuvant for vaccines in the developing world.","volume":"21","author":"LH Miller","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14760584.1.1.111","article-title":"Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.","volume":"1","author":"J Aucouturier","year":"2002","journal-title":"Expert Rev Vaccines"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.vaccine.2005.01.116","article-title":"The use of oil adjuvants in therapeutic vaccines.","volume":"24","author":"J Aucouturier","year":"2006","journal-title":"Vaccine"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.2003.02.124","article-title":"Immunotherapy of advanced breast cancer with a heterophilic ganglioside (NeuGcGM3) cancer vaccine.","volume":"21","author":"A Carr","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0264-410X(97)88327-2","article-title":"Safety and immunogenicity of REMUNE in HIV-infected Thai subjects.","volume":"16","author":"A Limsuwan","year":"1998","journal-title":"Vaccine"},{"key":"ref11","first-page":"3406","article-title":"A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive.","volume":"6","author":"L Muderspach","year":"2000","journal-title":"Clin Cancer Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/00002030-200305230-00002","article-title":"Augmentation of HIV-1-specific T helper cell responses in chronic HIV-1 infection by therapeutic immunization.","volume":"17","author":"GK Robbins","year":"2003","journal-title":"Aids"},{"key":"ref13","first-page":"74","article-title":"Safety and immunogenicity of a gp120-depleted, inactivated HIV-1 immunogen: results of a double-blind, adjuvant controlled trial.","volume":"10","author":"RJ Trauger","year":"1995","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/S0264-410X(02)00701-6","article-title":"Expression of malaria transmission-blocking vaccine antigen Pfs25 in <italic>Pichia pastoris<\/italic> for use in human clinical trials.","volume":"21","author":"L Zou","year":"2003","journal-title":"Vaccine"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/prep.2001.1613","article-title":"Large-Scale Purification and Characterization of Malaria Vaccine Candidate Antigen Pvs25H for Use in Clinical Trials.","volume":"25","author":"AP Miles","year":"2002","journal-title":"Protein Expr Purif"},{"key":"ref16","article-title":"Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris.","author":"CW Tsai","year":"2005","journal-title":"J Biotechnol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1016\/j.vaccine.2004.08.049","article-title":"Montanide ISA 720 vaccines: quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations.","volume":"23","author":"AP Miles","year":"2005","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vaccine.2007.10.064","article-title":"Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines.","volume":"26","author":"K Miura","year":"2008","journal-title":"Vaccine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.vaccine.2004.12.019","article-title":"Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.","volume":"23","author":"EM Malkin","year":"2005","journal-title":"Vaccine"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vaccine.2007.10.064","article-title":"Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines.","volume":"26","author":"K Miura","year":"2008","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.4049\/jimmunol.139.12.4213","article-title":"The 230-kDa gamete surface protein of Plasmodium falciparum is also a target for transmission-blocking antibodies.","volume":"139","author":"IA Quakyi","year":"1987","journal-title":"J Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.1016\/S0264-410X(99)00175-9","article-title":"Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant.","volume":"17","author":"A Saul","year":"1999","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1056\/NEJM199701093360202","article-title":"A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.","volume":"336","author":"JA Stoute","year":"1997","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/1475-2875-6-107","article-title":"Transmission-blocking activity induced by malaria vaccine candidates Pfs25\/Pvs25 is a direct and predictable function of antibody titer.","volume":"6","author":"K Miura","year":"2007","journal-title":"Malar J"},{"key":"ref25","article-title":"R: A language and environment for statistical computing","year":"2007"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.1007\/b98855","article-title":"Elements of large-sample theory","author":"EL Lehmann","year":"1999"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1128\/IAI.73.6.3677-3685.2005","article-title":"Phase 1 clinical trial of apical membrane antigen 1: an asexual blood-stage vaccine for Plasmodium falciparum malaria.","volume":"73","author":"EM Malkin","year":"2005","journal-title":"Infect Immun"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1073\/pnas.012590199","article-title":"A recombinant vaccine expressed in the milk of transgenic mice protects <italic>Aotus<\/italic> monkeys from a lethal challenge with <italic>Plasmodium falciparum<\/italic>.","volume":"99","author":"AW Stowers","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1586\/14760584.1.1.111","article-title":"Montanide ISA 720 and 51: a new generation of water in oil emulsions as adjuvants for human vaccines.","volume":"1","author":"J Aucouturier","year":"2002","journal-title":"Expert Rev Vaccines"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.vaccine.2005.01.116","article-title":"The use of oil adjuvants in therapeutic vaccines.","volume":"24","author":"J Aucouturier","year":"2006","journal-title":"Vaccine"},{"key":"ref31","first-page":"293","article-title":"Safety and immunogenicity of HIV-1 Tat toxoid in immunocompromised HIV-1-infected patients.","volume":"1","author":"A Gringeri","year":"1998","journal-title":"J Hum Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.pt.2005.07.005","article-title":"Revisiting Freund&apos;s incomplete adjuvant for vaccines in the developing world.","volume":"21","author":"LH Miller","year":"2005","journal-title":"Trends Parasitol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"8017","DOI":"10.1128\/IAI.73.12.8017-8026.2005","article-title":"Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen.","volume":"73","author":"R Audran","year":"2005","journal-title":"Infect Immun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.sder.2007.02.009","article-title":"Erythema nodosum.","volume":"26","author":"L Requena","year":"2007","journal-title":"Semin Cutan Med Surg"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1136\/bmj.301.6747.345","article-title":"Hepatitis B vaccine associated with erythema nodosum and polyarthritis.","volume":"301","author":"SJ Rogerson","year":"1990","journal-title":"BMJ"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM198910263211717","article-title":"Erythema nodosum after Recombivax HB hepatitis B vaccine.","volume":"321","author":"PL Goolsby","year":"1989","journal-title":"N Engl J Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S0140-6736(86)92654-1","article-title":"Erythema nodosum provoked by hepatitis B vaccine.","volume":"2","author":"CA Di Giusto","year":"1986","journal-title":"Lancet"},{"key":"ref38","first-page":"1417","article-title":"Erythema nodosum and Takayasu&apos;s arteritis after immunization with plasma derived hepatitis B vaccine.","volume":"20","author":"CJ Castresana-Isla","year":"1993","journal-title":"J Rheumatol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/003693308503000310","article-title":"Erythema nodosum following typhoid vaccination.","volume":"30","author":"BJ Thomson","year":"1985","journal-title":"Scott Med J"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.vaccine.2004.12.019","article-title":"Phase 1 vaccine trial of Pvs25H: a transmission blocking vaccine for Plasmodium vivax malaria.","volume":"23","author":"EM Malkin","year":"2005","journal-title":"Vaccine"},{"key":"ref41","first-page":"1","article-title":"Efficacy model for mosquito stage transmission blocking vaccines for malaria.","author":"A Saul","year":"2008","journal-title":"Parasitology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"e850","DOI":"10.1371\/journal.pone.0000850","article-title":"Human immunity and the design of multi-component, single target vaccines.","volume":"2","author":"A Saul","year":"2007","journal-title":"PLoS ONE"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0002636","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:59:29Z","timestamp":1684468769000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0002636"}},"subtitle":[],"editor":[{"given":"Adam J.","family":"Ratner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,7,9]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2008,7,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0002636","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,9]]}}}